Sandbox john2: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 1: | Line 1: | ||
==In Progress== | ==In Progress== | ||
Chemoprophylaxis | Chemoprophylaxis | ||
However, there must be robust trial evidence to demonstrate that the drug/s used for chemoprophylaxis are safe, effective and cost-efficient in terms of the number of new cases prevented. | However, there must be robust trial evidence to demonstrate that the drug/s used for chemoprophylaxis are safe, effective and cost-efficient in terms of the number of new cases prevented. | ||
On account of lack of consistent results from various studies using various drugs (dapsone, acedapsone, rifampicin) it is too premature to advise chemoprophylaxis as a public health measure. Further research is needed to use this as a routine tool to prevent the occurrence of disease among contacts. | On account of lack of consistent results from various studies using various drugs (dapsone, acedapsone, rifampicin) it is too premature to advise chemoprophylaxis as a public health measure. Further research is needed to use this as a routine tool to prevent the occurrence of disease among contacts. | ||
Revision as of 00:55, 5 July 2014
In Progress
Chemoprophylaxis
However, there must be robust trial evidence to demonstrate that the drug/s used for chemoprophylaxis are safe, effective and cost-efficient in terms of the number of new cases prevented. On account of lack of consistent results from various studies using various drugs (dapsone, acedapsone, rifampicin) it is too premature to advise chemoprophylaxis as a public health measure. Further research is needed to use this as a routine tool to prevent the occurrence of disease among contacts.
Random notes
